Related Experiment Video
Updated: Aug 16, 2026

Live/Dead Staining for Quantifying Viable but Not Culturable Cells in Manuka Honey-Treated Wound-Causing Bacteria
Published on: April 25, 2025
Wound care with antibacterial honey (Medihoney) in pediatric hematology-oncology
Arne Simon1, Kai Sofka, Gertrud Wiszniewsky
1Department of Pediatric Hematology and Oncology, Children's Hospital, University of Bonn, Adenauerallee 119, 53113 Bonn, Germany. asimon@ukb.uni-bonn.de
Insights
This study reviews the promising use of Medihoney for wound care in pediatric oncology patients undergoing chemotherapy. Honey preparations show antibacterial properties, aiding healing in immunocompromised children with difficult wounds.
Area of Science:
- Oncology
- Wound Healing
- Infectious Diseases
Background:
- Chemotherapy impairs wound healing and increases infection risk in pediatric patients.
- Immunosuppression in these patients can lead to sepsis from wound infections.
- Antibacterial properties of honey preparations are supported by in vitro studies.
Purpose of the Study:
- To review the scientific background of using Medihoney for wound care.
- To present promising clinical experience with Medihoney in pediatric oncology.
- To document pediatric wound care cases involving Medihoney.
Main Methods:
- Review of scientific literature on honey preparations and wound infections.
- Analysis of clinical data from pediatric oncology patients using Medihoney.
- Development of an internet-based data documentation module for wound care.
Main Results:
- Medihoney has been used successfully in wound care for 3 years at the Department of Pediatric Oncology, University of Bonn.
- Clinical data suggests promising outcomes in managing wounds in this patient population.
- The study aims to consolidate and analyze collected patient data.
Conclusions:
- Medihoney demonstrates potential as an effective treatment for wounds in pediatric oncology patients.
- Further data collection and analysis will support its clinical application.
- Special honey preparations offer a viable option for managing complex wounds in immunocompromised children.
Abstract:
The physiologic process of wound healing is impaired and prolonged in pediatric patients receiving chemotherapy. Due to profound immunosuppression, wound infection can easily spread and act as the source of sepsis. Referring to in vitro studies, which confirmed the antibacterial potency of special honey preparations against typical isolates of nosocomially acquired wound infections (including Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant enterococci) and considering the encouraging reports from other groups, Medihoney has now been used in wound care at the Department of Pediatric Oncology, Children's Hospital, University of Bonn for 3 years. Supplemented with clinical data from pediatric oncology patients, this article reviews the scientific background and our promising experience with Medihoney in wound care issues at our institution. To collect and analyze the available experience, we prepare an internet-based data documentation module for pediatric wound care with Medihoney.
Related Concept Videos
Hand hygiene
Hand washing...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy